HighTower Advisors »

Corcept Therapeutics Incorporated shares owned by HighTower Advisors

Quarter-by-quarter ownership of Corcept Therapeutics Incorporated (CORT) shares owned by HighTower Advisors from 13F filings

Historical chart of HighTower Advisors investment in Corcept Therapeutics Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Corcept Therapeutics Incorporated held by HighTower Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Corcept Therapeutics Incorporated by HighTower Advisors

Quarter filed Position value Share count Share price at filing
2024-06-30 $2.5M 78k 32.45
2024-03-31 $1.8M 72k 25.12
2023-12-31 $570k 17k 32.90
2023-09-30 $580k 21k 27.17
2017-12-31 $215k 12k 18.17

More positions owned by HighTower Advisors

Apple (AAPL)
Microsoft Corporation (MSFT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Core S&p500 Etf (IVV)
Berkshire Hathaway Inc Del Cl A (BRK.A)
Amazon (AMZN)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Exxon Mobil Corporation (XOM)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl A (GOOGL)
JPMorgan Chase & Co. (JPM)
Vanguard Index Fds Growth Etf (VUG)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Johnson & Johnson (JNJ)

View all positions for HighTower Advisors

Top funds holding Corcept Therapeutics Incorporated

BlackRock
BlackRock
Vanguard Group
Ingalls & Snyder
Renaissance Technologies
Parallel Advisors
State Street Corporation
Dimensional Fund Advisors
Novo A/S
Geode Capital Management
Arrowstreet Capital, Limited Partnership
Btim
First Trust Advisors
Morgan Stanley
Jacobs Levy Equity Management

View all funds holding Corcept Therapeutics Incorporated